1. Home
  2. MBIO vs XAIR Comparison

MBIO vs XAIR Comparison

Compare MBIO & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.77

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.51

Market Cap

5.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBIO
XAIR
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
5.4M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
MBIO
XAIR
Price
$0.77
$0.51
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
30.5K
330.7K
Earning Date
05-13-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
98.99
62.09
EPS
N/A
N/A
Revenue
N/A
$3,705,000.00
Revenue This Year
N/A
$122.00
Revenue Next Year
N/A
$58.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
219.67
52 Week Low
$0.53
$0.15
52 Week High
$7.00
$3.78

Technical Indicators

Market Signals
Indicator
MBIO
XAIR
Relative Strength Index (RSI) 49.51 35.12
Support Level $0.71 $0.43
Resistance Level $1.00 $0.82
Average True Range (ATR) 0.05 0.07
MACD 0.01 -0.00
Stochastic Oscillator 82.92 19.85

Price Performance

Historical Comparison
MBIO
XAIR

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

Share on Social Networks: